Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study.

medRxiv : the preprint server for health sciences·2026
Same author

Utility of liquid-based cytology and cell block obtained by vitrectomy under infusion to diagnose vitreoretinal lymphoma.

Japanese journal of ophthalmology·2026
Same author

Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies.

Journal of Alzheimer's disease : JAD·2026
Same author

Clinical and MRI features associated with amyloid positivity in secondary screening for anti-amyloid-β therapy.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Seed Amplification Assays for Parkinson's Disease: A Review of α-Synuclein Assays in Body Fluids and Tissues.

Journal of neurochemistry·2026
Same author

Comparison of percutaneous and transarterial fiducial marker placement before proton therapy for pancreatic cancer.

Journal of radiation research·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Kenichiro Sato1, Yoshiki Niimi2, Ryoko Ihara3

  • 1The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括

在阿尔茨海默病 (AD) 诊断中对功能进行血 fosforylated tau (p-tau) 校正会改变测试性能. 调整至关重要,特别是在慢性病 (CKD) 患者群体中,以确保精确的基于血液的生物标志物结果.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经退行性疾病的生物标志物
  • 临床诊断和绩效评估的临床诊断.

背景情况:

  • 化的 (p-tau) 显示出作为一种不那么侵入性的阿尔茨海默病 (AD) 生物标志物具有前途.
  • 慢性病 (CKD) 的p-tau升高需要仔细考虑功能纠正.
  • 功能正可以影响p-tau测定的灵敏度和特异性.

研究的目的:

  • 评估功能校正如何影响血p-tau测定的性能.
  • 为了量化由于功能纠正而导致的灵敏度和特异性的变化.
  • 评估CKD患病率对这些性能变化的影响.

主要方法:

  • 来自日本队列研究的血p-tau217数据的分析.
  • 具有和没有功能校正术语的预测模型的比较.
  • 在校正前后评估灵敏度和特异性的差异.

主要成果:

  • 功能校正降低了 ~ 0.06 的灵敏度,增加了 ~ 0.09 的特异性.
  • 样本中较高的CKD比例与更大的敏感性下降和特异性增加相关.
  • 绩效指标偏差虽然很小,但在CKD严重的队列中是显著的.

结论:

  • 功能校正对于在阿尔茨海默病中准确地应用基于血液的生物标志物 (BBM) 是至关重要的.
  • 校正对灵敏度和特异性的影响不是可以忽略不计的,特别是在CKD流行率高的情况下.
  • 建议披露研究样本中的CKD比例,以提供透明的BBM绩效报告.